TrialJournal of neurology2020

Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.

Alejandra González-Duarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.